KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Gains from Investment Securities (2017 - 2026)

Aquestive Therapeutics has reported Gains from Investment Securities over the past 9 years, most recently at $810000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 80900.0% year-over-year to $810000.0; the TTM value through Dec 2025 reached $810000.0, down 26.43%, while the annual FY2025 figure was $810000.0, 26.43% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $810000.0 at Aquestive Therapeutics, up from $46000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $1.1 million in Q3 2024 and troughed at -$1.0 million in Q2 2024.
  • A 5-year average of $113411.8 and a median of $7000.0 in 2023 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: crashed 14700.0% in 2024 and later soared 80900.0% in 2025.
  • Year by year, Gains from Investment Securities stood at -$234000.0 in 2021, then skyrocketed by 126.92% to $63000.0 in 2022, then tumbled by 479.37% to -$239000.0 in 2023, then skyrocketed by 100.42% to $1000.0 in 2024, then soared by 80900.0% to $810000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for AQST at $810000.0 in Q4 2025, $46000.0 in Q2 2025, and -$46000.0 in Q1 2025.